Search

Your search keyword '"Urtasun Arlegui L"' showing total 12 results
Start Over Author "Urtasun Arlegui L"
12 results on '"Urtasun Arlegui L"'

3. Sprue-like enteropathy linked to olmesartan

Author

Urtasun Arlegui L, Marra-López Valenciano C, and Campos Ruiz A

Subjects
Male, medicine.medical_specialty, Tetrazoles, 030204 cardiovascular system & hematology, Gastroenterology, Sprue, Serology, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Biopsy, medicine, Humans, Enteropathy, 030212 general & internal medicine, Villous atrophy, Aged, medicine.diagnostic_test, business.industry, Imidazoles, General Medicine, Middle Aged, medicine.disease, Discontinuation, Celiac Disease, Hypertension, Differential diagnosis, Olmesartan, business, Angiotensin II Type 1 Receptor Blockers, medicine.drug
Abstract

Olmesartan is a therapy used for the management of hypertension available since 2002. A sprue like enteropathy associated with olmesartan has been first described in 2012. Endoscopic and histopathological findings are partial or total villous atrophy, mimicking a Celiac Disease. We explain two cases diagnosed in our hospital. Both patients took more than one year of treatment with olmesartan. In both cases, the biopsy showed duodenal villous atrophy, negative serology for celiac disease and they improved after stopping treatment with olmesartan. Olmesartan associate sprue-like enteropathy should be included in the differential diagnosis of seronegative villous atrophy. After the discontinuation of olmesartan, clinical remission usually occurs in every patients.

Published
2016

8. ESTUDIO PROSPECTIVO DE CALIDAD Y COMPLICACIONES EN ENDOSCOPIA "AVANZADA", COLANGIOPANCREATOGRAFIA RETROGRADA ENDOSCOPICA (CPRE) Y ULTRASONOGRAFIA ENDOSCÓPICA (USE)

Author

Marra-López, C, primary, Enciso, C, additional, Salvador, M, additional, Sanchez, C, additional, Valero, C, additional, Arias, C, additional, López-Barbarin, JM, additional, Marcaide, M, additional, Spicakova, K, additional, Urtasun Arlegui, L, additional, and García Campos, F, additional

Published
2013
Full Text
View/download PDF

10. Eosinophilic gastroenteritis: three clinical cases with different presentations.

Author

Campos Ruiz A, Ganchegui Aguirre I, Urtasun Arlegui L, Fernández Laso AB, Spicakova K, Salvador Pérez M, Oncins SE, Ibarrola M, Niso JB, Aguirre Anda JJ, and Orive-Calzada A

Subjects
Adrenal Cortex Hormones therapeutic use, Adult, Aged, Biopsy, Early Diagnosis, Enteritis diagnostic imaging, Enteritis drug therapy, Eosinophilia diagnostic imaging, Eosinophilia drug therapy, Female, Gastritis diagnostic imaging, Gastritis drug therapy, Gastroscopy, Humans, Male, Middle Aged, Recurrence, Tomography, X-Ray Computed, Ultrasonography, Enteritis diagnosis, Eosinophilia diagnosis, Gastritis diagnosis
Published
2017
Full Text
View/download PDF

11. [Hypertrophic pyloric stenosis in adults].

Author

Fernández Laso AB, Ganchegui Aguirre I, Campos Ruiz A, Urtasun Arlegui L, Gorroño Zamalloa I, Martinez Blazquez C, Carreter De Granda ME, Atares Pueyo MB, and Orive Calzada A

Subjects
Aged, Emergencies, Esophagoplasty, Female, Gastrectomy, Gastric Dilatation surgery, Humans, Jejunostomy, Pneumoperitoneum etiology, Pyloric Stenosis, Hypertrophic diagnostic imaging, Pyloric Stenosis, Hypertrophic surgery, Gastric Dilatation etiology, Pyloric Stenosis, Hypertrophic complications
Published
2016
Full Text
View/download PDF

12. Sprue-like enteropathy linked to olmesartan.

Author

Campos Ruiz A, Urtasun Arlegui L, and Marra-López Valenciano C

Subjects
Aged, Angiotensin II Type 1 Receptor Blockers therapeutic use, Celiac Disease diagnostic imaging, Humans, Hypertension complications, Hypertension drug therapy, Imidazoles therapeutic use, Male, Middle Aged, Tetrazoles therapeutic use, Angiotensin II Type 1 Receptor Blockers adverse effects, Celiac Disease chemically induced, Imidazoles adverse effects, Tetrazoles adverse effects
Abstract

Olmesartan is a therapy used for the management of hypertension available since 2002. A sprue like enteropathy associated with olmesartan has been first described in 2012. Endoscopic and histopathological findings are partial or total villous atrophy, mimicking a Celiac Disease. We explain two cases diagnosed in our hospital. Both patients took more than one year of treatment with olmesartan. In both cases, the biopsy showed duodenal villous atrophy, negative serology for celiac disease and they improved after stopping treatment with olmesartan. Olmesartan associate sprue-like enteropathy should be included in the differential diagnosis of seronegative villous atrophy. After the discontinuation of olmesartan, clinical remission usually occurs in every patients.

Published
2016
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results